Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

S-APP-alpha is a possible biomarker in fragile X syndrome and autism

May 23, 2011

Denosumab delays pain interference in patients with CRPC

May 23, 2011

Dutasteride reduces risk of prostate cancer in men with small prostates

May 23, 2011

Chemical genetics screening platform identifies new agent and target for influenza therapy

May 20, 2011

Armodafinil improves severe sleepiness in subjects with shift work disorder

May 20, 2011

Stem cell therapy shows promise to treat diabetic retinopathy and optical neuropathy

May 20, 2011

Abiraterone acetate plus prednisone provides clinical benefit in metastatic CRPC

May 20, 2011

Tofacitinib is efficacious in phase II trial in ulcerative colitis

May 19, 2011

Nizatidine improves symptoms of functional dyspepsia

May 19, 2011

JNJ-37822681 shows efficacy and promising metabolic profile in phase II trial in schizophrenia

May 19, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...